SCHEMBL30665368

SCHEMBL30665368

O=C1c2ccccc2C(=O)C1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.55
KMT2A Q03164 7/20 0.55
S100A4 P26447 3/20 0.55
POLB P06746 2/20 0.55
MAPT P10636 5/20 0.54
HBB P68871 2/20 0.54
HTT P42858 2/20 0.54
ALOX15 P16050 1/20 0.54
CYP1A2 P05177 2/20 0.50
LMNA P02545 2/20 0.50
TP53 P04637 2/20 0.50
MAPK1 P28482 2/20 0.50
CYP3A4 P08684 1/20 0.50
HTR2B P41595 1/20 0.50
KDM4E B2RXH2 2/20 0.48
PIM1 P11309 1/20 0.48
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10344203 1.00 MEN1 (0.55) MEN1KMT2AS100A4POLBMAPT
SCHEMBL20099086 0.83 MAPT (0.45) MEN1KMT2AS100A4POLBMAPT
SCHEMBL11509568 0.83 MAPT (0.50) MEN1KMT2AS100A4POLBMAPT
SCHEMBL6081753 0.82 MEN1 (0.55) MEN1KMT2AS100A4POLBMAPT
SCHEMBL15906510 0.81 CYP2D6 (0.47) MEN1KMT2AS100A4POLBMAPT
SCHEMBL5940241 0.79 MAPT (0.47) MEN1KMT2AS100A4POLBMAPT
SCHEMBL2205822 0.78 S100A4 (0.56) MEN1KMT2AS100A4POLBMAPT
SCHEMBL12726414 0.78 ALDH1A1 (0.56) MEN1KMT2APOLBMAPTHTT
SCHEMBL9389657 0.74 MAOA (0.54) MEN1KMT2APOLBMAPTHTT
SCHEMBL22785968 0.73 MAPT (0.42) MEN1KMT2AS100A4POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4360710-A2 1,3-DI-OXO-INDENE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ANTIVIRAL, ACTIVE INGREDIENT Korea Research Institute of Chemical Technology (KR) 2024-05-01 EP disclosed
EP-3611158-B1 1,3-DI-OXO-INDENE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ANTIVIRAL, ACTIVE INGREDIENT KOREA RES INST CHEMICAL TECH (KR) 2023-12-20 EP disclosed